Lipocine Inc. - Common Stock (LPCN)

$3.16 0.01 (0.32%)

10:37 EST LPCN Stock Quote Delayed 30 Minutes

7 Pharmaceutical Stocks to Buy Now

By Portfolio Grader Apr 10, 2015

This week, seven pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

6 Pharmaceutical Stocks to Buy Now

7 Pharmaceutical Stocks to Buy Now

6 Pharmaceutical Stocks to Buy Now

Volume:

Previous Close -

Market Cap 16.90M

PE Ratio -4.16

EPS -0.76

Volume (Avg. Vol.) 1,552

Day's Range $3.16 - $3.21

52-Week Range $2.96 - $11.79

Dividend & Yield N/A (N/A)

LPCN Stock Predictions, Articles, and Lipocine Inc. - Common Stock News

6 Pharmaceutical Stocks to Buy Now

By Portfolio Grader Mar 13, 2015

This week, six pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Mar 6, 2015

The overall ratings of three pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Feb 27, 2015

The ratings of three pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Feb 20, 2015

For the current week, the overall ratings of three pharmaceutical stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Feb 6, 2015

This week, the ratings of five pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Jan 30, 2015

This week, the overall grades of three pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Jan 16, 2015

The ratings of three pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Jan 9, 2015

This week, the overall grades of five pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader Oct 24, 2014

This week, the ratings of three pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").